FDA Designations for Rare Disease Products, Part 3: Rare Pediatric Disease Designation
Camargo
MARCH 25, 2021
Its purpose is to stimulate the development of new drugs for rare pediatric diseases by offering additional incentives for obtaining FDA approval of such products beyond the incentives offered by the ODD program. The FDA must deem the application eligible for priority review (i.e.,
Let's personalize your content